16-75545825-C-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_001077418.3(TMEM231):c.438+1G>C variant causes a splice donor, intron change. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001077418.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Joubert syndrome 20Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome IIIInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001077418.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TMEM231 | NM_001077418.3 | MANE Select | c.438+1G>C | splice_donor intron | N/A | NP_001070886.1 | |||
| TMEM231 | NM_001077416.2 | c.597+1G>C | splice_donor intron | N/A | NP_001070884.2 | ||||
| TMEM231 | NR_074083.2 | n.604+1G>C | splice_donor intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TMEM231 | ENST00000258173.11 | TSL:1 MANE Select | c.438+1G>C | splice_donor intron | N/A | ENSP00000258173.5 | |||
| TMEM231 | ENST00000568377.5 | TSL:1 | c.525+1G>C | splice_donor intron | N/A | ENSP00000476267.1 | |||
| TMEM231 | ENST00000565067.5 | TSL:5 | c.438+1G>C | splice_donor intron | N/A | ENSP00000457254.1 |
Frequencies
GnomAD3 genomes Cov.: 13
GnomAD4 exome Cov.: 15
GnomAD4 genome Cov.: 13
ClinVar
Submissions by phenotype
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Pathogenic:1
This sequence change affects a donor splice site in intron 2 of the TMEM231 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TMEM231 are known to be pathogenic (PMID: 23012439, 23349226). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of Joubert syndrome (PMID: 32055034, 32386258). ClinVar contains an entry for this variant (Variation ID: 1192252). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Joubert syndrome and related disorders Pathogenic:1
Variant summary: TMEM231 c.597+1G>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5 prime splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 100746 control chromosomes. To our knowledge, no occurrence of c.597+1G>C in individuals affected with Joubert Syndrome And Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at